In addition, MIAT is found to be increased in a mouse diabetes model and in vitro after high glucose treatment [40,42], which is at least partially the effect of increased binding of the protein complex NF-κB to the MIAT promotor. The gene discussed is MIAT; the disease is diabetes mellitus.